Helicobacter pylori cytotoxic genotype is associated with peptic ulcer and influences serology

American Journal of Gastroenterology

Volumn 93, Issue 2, 1998, Pages 227-230

  Navaglia, F ^a   Basso, D ^a   Piva, M G ^a   Brigato, L ^a   Stefani, A ^a   Dal Bo N ^a   Di Mario, F ^a   Rugge, M ^a   Plebani, M ^a,b  

^a UNIVERSITY HOSPITAL OF PADOVA   (Italy)

^b Servizio di Medicina di Laboratorio   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM ANTIBODY; CYTOTOXIN; DNA; IMMUNOGLOBULIN G; PEPSINOGEN; PEPSINOGEN II;

ADULT; AGED; ALLELE; ARTICLE; BACTERIAL GENE; CONTROLLED STUDY; CYTOTOXICITY; DUODENITIS; FEMALE; GASTRITIS; GASTROENTERITIS; GENOTYPE; HELICOBACTER PYLORI; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PEPTIC ULCER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SEROLOGY; STOMACH JUICE;

ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, BACTERIAL; CYTOTOXINS; DNA, BACTERIAL; DUODENITIS; FEMALE; GASTRITIS; GENES, BACTERIAL; GENOTYPE; HELICOBACTER PYLORI; HUMANS; MALE; MIDDLE AGED; PEPSINOGENS; PEPTIC ULCER; POLYMERASE CHAIN REACTION; UREASE;

EID: 0032008384     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.1998.00227.x     Document Type: Article

References (27)

1. 1. Cover TL. The vacuolating cytotoxin of Helicobacter pylori. Mol Microbiol 1996;20:241-6.
2. 2. Cover TL, Blaser MJ. Purification and characterization of the vacuolating toxin from Helicobacter pylori. J Biol Chem 1992;267:10570-5.
3. 3. Cover TL, Reddy LY, Blaser MJ. Effects of ATPase inhibitors on the response of HeLa cells to Helicobacter pylori vacuolating toxin. Infect Immun 1993;61:1427-31.
4. 4. Papini E, de Bernard M, Milia E, et al. Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci USA 1994;91:9720-4.
5. 5. De Bernard M, Papini E, de Filippis V, et al. Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem 1995;270:23937-40.
6. 6. Cover TL, Tummuru MKR, Cao P, et al. Divergence of genetic sequences for the vacuolating cytotoxin among Helicobacter pylori strains. J Biol Chem 1994;269:10566-73.
7. 7. Atherton JC, Cao P, Peek RM, et al. Mosaicism in vacuolating cytotoxin alleles of Helicobacter pylori. Association of specific vacA types with cytotoxin production and peptic ulceration. J Biol Chem 1995; 270:17771-7.
8. 8. Xiang Z, Censini S, Bayeli PF, et al. Analysis of expression of cagA and vacA virulence factors in 43 strains of Helicobacter pylori reveals that clinical isolates can be divided into two major types and that cagA is not necessary for expression of the vacuolating cytotoxin. Infect Immun 1995;63:94-8.
9. 9. Covacci A, Censini S, Bugnoli M, et al. Molecular characterization of the 128-kDa immunodominant antigen of Helicobacter pylori associated with cytotoxicity and duodenal ulcer. Proc Natl Acad Sci USA 1993;90:5791-5.
10. 10. Crabtree JE, Wyatt JI, Trejdosiewicz LK, et al. Interleukin-8 expression in Helicobacter pylori infected, normal, and neoplastic gastroduodenal mucosa. J Clin Pathol 1994;47:61-6.
11. 11. Karttunen R, Karttunen T, Ekre H-PT, et al. Interferon gamma and interleukin 4 secreting cells in the gastric antrum in Helicobacter pylori positive and negative gastritis. Gut 1995;36:341-5.
12. 12. Basso D, Scrigner M, Toma A, et al. Helicobacter pylori infection enhances mucosal interleukin 1-beta, interleukin 6 and the soluble receptor of interleukin-2. Int J Clin Lab Res 1996;26:207-210.
13. 13. Plebani M. Pepsinogens in health and disease. Crit Rev Clin Lab Sci 1993;30:273-328.
14. 14. Plebani M, Di Mario F, Stanghellini V, et al. Serological tests to monitor treatment of Helicobacter pylori. Lancet 1992;340:51-2.
15. 15. Plebani M, Basso D, Scrigner M, et al. Serum pepsinogen C: A useful marker of Helicobacter pylori eradication? J Clin Lab Anal 1996;10: 1-5.
16. 16. Kosunen TU, Seppala K, Sarna S, et al. Diagnostic value of decreasing IgG, IgA, and IgM antibody titres after eradication of Helicobacter pylori. Lancet 1992;339:893-5.
17. 17. Blecker U, Lanciers S, Hauser B, et al. Serology as a valid screening test for Helicobacter pylori infection in asymptomatic subjects. Arch Pathol Lab Med 1995;119:30-2.
18. 18. Cutler AF, Havstad S, Ma CK, et al. Accuracy of invasive and non invasive tests to diagnose Helicobacter pylori infection. Gastroenterology 1995;109:136-41.
19. 19. Plebani M, Basso D, Cassaro M, et al. Helicobacter pylori serology in patients with chronic gastritis. Am J Gastroenterol 1996;91:954-8.
20. 20. Blaser MJ, Perez-Perez GI, Kleanthous H, et al. Infection with Helicobacter pylori strains possessing cagA is associated with an increased risk of developing adenocarcinoma of the stomach. Cancer Res 1995; 55:2111-5.
21. 21. Basso D, Navaglia F, Cassaro M, et al. Gastric juice polymerase chain reaction: An alternative to histology in the diagnosis of Helicobacter pylori infection. Helicobacter 1996;1:159-64.
22. 22. Tummuru MKR, Cover TL, Blaser MJ. Cloning and expression of a high-molecular-mass major antigen of Helicobacter pylori: Evidence of linkage to cytotoxin production. Infect Immun 1993;61: 1799-809.
23. 23. Ricci V, Ciacci C, Zarrilli R, et al. Effect of Helicobacter pylori on gastric epithelial cell migration and proliferation in vitro: Role of vacA and cagA. Infect Immun 1996;64:2829-33.
24. 24. Lambert JR, Lin SK, Aranda-Michel J. Helicobacter pylori. Scand J Gastroenterol Suppl 1995;30:33-46.
25. 25. Blaser MJ. Helicobacter pylori phenotypes associated with peptic ulceration. Scand J Gastroenterol Suppl 1994;29:1-5.
26. 26. Telford JL, Ghiara P, Dell'Orco M, et al. Gene structure of the Helicobacter pylori cytotoxin and evidence of its key role in gastric disease. J Exp Med 1994;179:1653-8.
27. 27. Crabtree JE, Farmery SM, Lindley IJD, et al. CagA/cytotoxic strains of Helicobacter pylori and interleukin-8 in gastric epithelial cell lines. J Clin Pathol 1994;47:945-50.